AmbiJet: the world’s first and only highly effective plasma-based solution for Europe’s 16 Million periimplantitis patients urgently needing help to avoid losing their dental implant

Project Information

AmbiJet

Grant agreement ID: 190173644

DOI 10.3030/190173644

EC signature date 14 September 2022

Start date 1 October 2022

End date 30 September 2024

Funded under

• The European Innovation Council (EIC)

Total cost € 1 984 375,00

EU contribution € 1 389 062,00

Coordinated by

FREIBURGER MEDIZINTECHNIK GMBH
Germany

Project description

In situ oral disinfection with plasma technology

Oral hygiene is important not only for aesthetic reasons but also for overall health as gum disease and subsequent inflammation have been linked to heart and kidney disease. Funded by the European Innovation Council, the AmbiJet project is introducing a proprietary technology that permits in situ disinfection of and around dental implants. The solution is based on plasma technology, has no side effects, and demonstrates superior effectiveness to current treatment options. Furthermore, it reduces the chance of re-infection, sparing further patient suffering.

Objective

Regular dental check-ups and treatments not only ensure a beautiful smile, but good general health: a healthy oral cavity strengthens the immune system and acts as a barrier against various heart-, kidney-, or lungs-related diseases and diabetes. There is currently no effective solution to treat the 16.3 mn infected dental implants (EU, 2019). Freiburger Medizintechnik GmbH developed the solution dentists are looking for: a disruptive technology for highly effective infection control to fight periimplantitis. AmbiJet® is the world’s first and only plasma-based technology with the ability to kill bacteria on dental implants in-situ. It disrupts the status-quo of medical technologies by preventing the reinfection of disinfected surfaces and shows maximum effectiveness without side nor adverse effects: pharmacological and chemical substances are no longer required. AmbiJet® reduces inflammation, saves dental implants and helps patients live a healthier life.

Fields of science

• medical and health sciences › clinical medicine › odontology › dental implantology
• natural sciences › biological sciences › microbiology › bacteriology
• medical and health sciences › clinical medicine › endocrinology › diabetes
• medical and health sciences › basic medicine › immunology
• medical and health sciences › medical biotechnology › implants

Programme(s)

• HORIZON.3.1 - The European Innovation Council (EIC) Main Programme

Topic(s)

• HORIZON-EIC-2022-ACCELERATOROPEN-01 - EIC Accelerator Open

Call for proposal

HORIZON-EIC-2022-ACCELERATOR-01

Funding Scheme

HORIZON-AG - HORIZON Action Grant Budget-Based

Coordinator

FREIBURGER MEDIZINTECHNIK GMBH

• Net EU contribution: € 1 389 062,00
• Address: SCHWESTER-ADOLFA-WEG 34 ; 79115 FREIBURG ; Germany
• SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes:
  Region
  Baden-Württemberg › Freiburg › Freiburg im Breisgau, Stadtkreis
• Region: Baden-Württemberg › Freiburg › Freiburg im Breisgau, Stadtkreis
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Total cost: € 1 984 375,00